239 related articles for article (PubMed ID: 2658896)
1. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis.
Chow JW; Yu VL
Arch Intern Med; 1989 Jun; 149(6):1258-62. PubMed ID: 2658896
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.
Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ
N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
5. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
6. Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials.
Falagas ME; Fragoulis KN; Bliziotis IA
Nephrol Dial Transplant; 2006 Sep; 21(9):2536-42. PubMed ID: 16705024
[TBL] [Abstract][Full Text] [Related]
7. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
[TBL] [Abstract][Full Text] [Related]
8. Frequency of nasal carriage of Staphylococcus aureus and its antimicrobial resistance pattern in patients on hemodialysis.
Ghasemian R; Najafi N; Makhlough A; Khademloo M
Iran J Kidney Dis; 2010 Jul; 4(3):218-22. PubMed ID: 20622310
[TBL] [Abstract][Full Text] [Related]
9. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
[TBL] [Abstract][Full Text] [Related]
11. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections.
Kluytmans JA; Wertheim HF
Infection; 2005 Feb; 33(1):3-8. PubMed ID: 15750752
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus infections during peritoneal dialysis.
Coles GA
J Chemother; 1995 Jul; 7 Suppl 3():67-70. PubMed ID: 8609540
[TBL] [Abstract][Full Text] [Related]
13. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS).
Oh J; von Baum H; Klaus G; Schaefer F
Adv Perit Dial; 2000; 16():324-7. PubMed ID: 11045321
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization.
Peña C; Fernández-Sabe N; Domínguez MA; Pujol M; Martinez-Castelao A; Ayats J; Gudiol F; Ariza J
J Hosp Infect; 2004 Sep; 58(1):20-7. PubMed ID: 15350709
[TBL] [Abstract][Full Text] [Related]
15. Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients.
Patel R
Liver Transpl; 2001 Aug; 7(8):752-3. PubMed ID: 11780649
[No Abstract] [Full Text] [Related]
16. Preventing postoperative Staphylococcus infections: an update.
Grady M; Cullen JJ
Surg Technol Int; 2003; 11():57-60. PubMed ID: 12931284
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology and prevention of Staphylococcus aureus infections during hemodialysis].
Boelaert JR; Van Landuyt HW; De Baere YA; Gheyle DW; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
Nephrologie; 1994; 15(2):157-61. PubMed ID: 8047204
[TBL] [Abstract][Full Text] [Related]
18. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review.
Boelaert JR
J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
Bloom BS; Fendrick AM; Chernew ME; Patel P
Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
